Elena Ibáñez

Descargar

Info

Experiencias profesionales

Design, synthesis and biological evaluation of alkylthio- and alkylseleno-imidocarbamates as antitumor agents (Doctoral thesis research)
Estancia en el extranjero (17 Mar.-17 Jun., 2010): Lugar: Institut für Experimentelle Endokrinologie – Charité, University of Medicine, Südring 10, Campus Virchow-Klinikum, Berlin (Alemania). Financiación: Beca de Movilidad, Ministerio de Educación.
Publicaciones en revistas científicas:
Plano D, Baquedano Y, Ibáñez E, Jiménez I, Pajop JA, Spallhoz J, Sanmartin C. Antioxidant-Prooxidant properties of a new organoselenium compound library. Molecules 2010; 15(10):7292-7312.
Ibáñez E, Plano D, Font M, Calvo P, Prior C, Palop JA, Sanmartín C. Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylselenocarbamates. Eur J Med Chem 2011; 46(1): 265-274.
Plano D, Ibáñez E, Palop J, Sanmartín C. Synthesis, characterization, crystal structure and cytotoxicity of 2,4-bis(selenomethyl)quinazoline. Struct Chem 2011; 22(6):1233-1240.
Plano D,Ibáñez E, Calvo A , Palop JA Sanmartín C. Novel library of selenocompounds as kinase modulators. Molecules 2011; 16(8): 6349-6364.
Ibáñez E, Agliano A, Prior C, Nguewa P, Redrado M, Gonzalez-Zubeldia I, Plano D, Palop JA, Sanmartin C, Calvo A. The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity. Curr Med Chem 2012;19(18):3031-3043.